M. S. Kurte

Cost-effectiveness analysis of transplant-ineligible relapsed or refractory diffuse large B-cell lymphoma treatment options-Experience of the efficiency frontier approach.

B. von Tresckow, F. Kron, H. Reinhardt, 2023, European journal of haematology.